Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO
August 21, 2018 — 11:01 CST
This Data Is Locked!
This area is available only to Subscribers.
Suzhou-based biopharmaceutical company Ascentage Pharma Group International has filed for an initial public offering in Hong Kong, according to its IPO prospectus. Following Hangzhou-based Ascletis... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals